Aptinyx Inc reported $106.53M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Acorda Therapeutics ACOR:US $ 80.46M 21.7M
Biogen BIIB:US $ 7915.9M 59.4M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Daiichi Sankyo 4568:JP Y 1345271M 34628M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Marinus Pharmaceuticals MRNS:US $ 135.07M 3.39M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M